Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PPD names new executive vice president and CMO
Prior to joining PPD, Dr Dingivan spent 12 years with MedImmune, a worldwide biologics business acquired by AstraZeneca. Dr Dingivan earned her undergraduate degree in bioengineering from the
Prior to joining PPD, Dr Dingivan spent 12 years with MedImmune, a worldwide biologics business acquired by AstraZeneca. Dr Dingivan earned her undergraduate degree in bioengineering from the
The therapeutic areas included in these awards are cardiovascular diseases, oncology, diabetes, and infectious diseases. Services, which will be provided in both North America and Europe, include medical/scientific
The company said that the trial is unlikely to meet the forecast patient recruitment timetable and further significant delays were expected due to – slower than expected regulatory
The driving force behind this new agreement was Datascope’s customer demand for Starion’s Tissue Welding technology, which uses direct heat and pressure to simultaneously seal and divide soft
The assets include selected microbial strains, a substantial gene collection (Tool-Box) encoding modifying enzymes and a huge collection of cosmid libraries comprising more than 800,000 cosmids, harboring some
The patent covers Cara’s second generation, peripherally-selective kappa opioid receptor agonist compounds. These compounds include CR845, currently completing a Phase I clinical trial and in development for injectable
Teva’s Lamotrigine tablets are the AB-rated generic equivalent of GlaxoSmithKline’s Lamictal tablets, and are indicated as adjunctive therapy in the treatment of partial seizures and the generalized seizures
The study is designed to assess the non-inferiority of ritonavir-boosted elvitegravir, dosed once daily, compared to raltegravir (Isentress), another integrase inhibitor that is dosed twice daily. The study
Dyax’s human antibody phage libraries combine gene fragments from human donors with strategically designed synthetic DNA, and are used to identify high-affinity human antibodies that bind to numerous
Mr Liang joins Vascular Therapies from Cordis, a Johnson & Johnson company, where most recently he was vice president of worldwide commercial operations. Mr Liang earned a Masters